[1]
Ichimura, Y. et al. 2018. Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 34, 4 (Feb. 2018), 290–299. DOI:https://doi.org/10.36141/svdld.v34i4.5630.